(2026). PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo. Bioengineering & Translational Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"PEGylated Thymosin β4 Is a Thiol‐site‐specific Prodrug Treating Myocardial Infarction in Vivo."
Bioengineering & Translational Medicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"PEGylated Thymosin β4 Is a Thiol‐site‐specific Prodrug Treating Myocardial Infarction in Vivo."
Bioengineering & Translational Medicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.